November 2014
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC
2
FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis
3
Second Known Case of Concurrent ET, WM Raises Questions About Their Coexistence
4
CSU More Burdensome in Female Patients, Especially in Midlife
5
